
Oncologist

No OPD information available
Colorectal Cancer
Agranulocytosis
Appendix Cancer
Breast Cancer
Breast Infection
Carcinoid Syndrome
Colonoscopy
Ependymoma
Esophageal Cancer
Febrile Neutropenia
Gastroesophageal Junction Cancer
Gastrointestinal Stromal Tumor
Liver Cancer
Lung Cancer
Lung Metastases
Metastatic Brain Tumor
Neuroendocrine Tumor
Pancreatic Cancer
Spinal Tumor
Stomach Cancer
Triple-Negative Breast Cancer
Turcot Syndrome
Timothy J. Price is a male doctor who helps people with different types of cancer like colorectal cancer, breast cancer, and lung cancer. He also treats conditions such as agranulocytosis, appendix cancer, and stomach cancer. Timothy J. Price is skilled in performing procedures like colonoscopies and treating rare cancers like carcinoid syndrome and ependymoma.
Patients trust Timothy J. Price because he listens to them carefully and explains things in a way that is easy to understand. He is kind, compassionate, and always makes sure his patients feel comfortable and cared for. Timothy J. Price stays updated with the latest medical knowledge and research by attending conferences, reading medical journals, and collaborating with other experts in the field.
Timothy J. Price works closely with his colleagues and values teamwork. He believes that by working together, they can provide the best care possible for their patients. His collaborative approach has led to successful outcomes for many patients. Timothy J. Price's research on using medicinal cannabis to help cancer patients manage chemotherapy side effects has been published in a prestigious medical journal.
One of Timothy J. Price's notable clinical trials focused on finding better treatments for metastatic colorectal cancer. This trial was completed successfully, showing his dedication to advancing cancer care. Timothy J. Price's work has had a positive impact on many patients' lives, offering hope and improving their quality of life.
In summary, Timothy J. Price is a caring and knowledgeable doctor who specializes in treating various types of cancer. He is respected for his expertise, communication skills, and commitment to improving patient outcomes through research and collaboration with other healthcare professionals.
Enrollment Status: Completed
Published: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
